comparemela.com

Page 6 - செய்ம் ஷெபா மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer/BioNTec vaccines proved 95% effective, finds the largest study

Pfizer/BioNTec vaccines proved 95% effective, finds the largest study Health Thu, May 06, 2021 PARIS: The largest real-world study yet of the Pfizer/BioNTec vaccine on Thursday confirmed that the jab provided more than 95 percent protection against Covid-19, but found that the level dropped significantly when people received just one of the two prescribed doses. The authors of the research from Israel´s national vaccination campaign said it showed real-world proof that the pandemic could be ended by rapid, global vaccination programmes. An analysis of public health data from Israel one of the countries with the highest proportion of fully vaccinated adults showed the vaccine was extremely effective in protecting even elderly individuals at a time when the more infectious English variant was dominant, according to the results published in the Lancet medical journal.

The Lancet: First nation-wide data shows two doses of Pfizer-BioNTech vaccine highly effective against COVID-19 infection, hospitalisation, and death

 E-Mail Israel is the first country to report national data on the Pfizer-BioNTech vaccine, with observational analysis showing that two doses provide more than 95% protection against COVID-19 infection, hospitalisation, and death, including among the elderly, at a time when the B.1.1.7 variant was the dominant strain. A single dose of the vaccine was associated with 58% protection against infection, 76% against hospitalisation, and 77% against death, emphasising the importance of fully vaccinating adults. Challenges to controlling the pandemic remain, including uncertainty about the duration of immunity, the possible emergence of vaccine-resistant variants, and the need to increase vaccine coverage. Two doses of the Pfizer-BioNTech COVID-19 vaccine provide more than 95% protection against infection, hospitalisation, severe illness, and death, including among the elderly, according to the first national-level observational assessment of its effectiveness in Israel, published i

Pfizer/BioNTech jab confirmed to protect 95% in largest study yet

Pfizer/BioNTech jab confirmed to protect 95% in largest study yet AFP 5/5/2021 AFP © JACK GUEZ Authors of the research said it showed real-world proof that the pandemic could be ended by rapid, global vaccination programmes The largest real-world study yet of the Pfizer/BioNTec vaccine  on Thursday confirmed that the jab provided more than 95 percent protection against Covid-19, but found that the level dropped significantly when people received just one of the two prescribed doses. The authors of the research from Israel s national vaccination campaign said it showed real-world proof that the pandemic could be ended by rapid, global vaccination programmes.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.